We estimate that the CEO of BADGER METER INC ($BMI), Kenneth C. Bockhorst, received a compensation of $5,932,862 in 2025. This is an increase of 14.3% from an estimated $5,084,577 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on March 13, 2026. Note that parsing errors may occur.
You can track $BMI on Quiver Quantitative's $BMI stock dashboard.
$BMI Stock Insider Trading Activity
$BMI Stock insiders have traded $BMI stock on the open market 6 times in the past 6 months. Of those trades, 2 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $BMI stock by insiders over the last 6 months:
- KENNETH BOCKHORST (Chairman, President & CEO) purchased 3,300 shares for an estimated $502,985
- FRED J BEGALE (VP-Utility NPD) sold 2,064 shares for an estimated $309,600
- KIMBERLY K STOLL (VP-Cust Serv & GM SmartCover) has made 0 purchases and 3 sales selling 1,925 shares for an estimated $286,399.
- ROBERT WROCKLAGE (EVP-N.A. Muncipal Utility) purchased 1,650 shares for an estimated $251,377
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BMI Stock Government Contracts
We have seen $184,526 of award payments to $BMI over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
$BMI Stock Hedge Fund Activity
We have seen 233 institutional investors add shares of $BMI Stock stock to their portfolio, and 312 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WESTFIELD CAPITAL MANAGEMENT CO LP removed 612,809 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $109,435,431
- UBS GROUP AG added 335,953 shares (+89.2%) to their portfolio in Q4 2025, for an estimated $58,593,562
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 233,255 shares (-74.9%) from their portfolio in Q4 2025, for an estimated $40,682,004
- PICTET ASSET MANAGEMENT HOLDING SA added 212,448 shares (+39.2%) to their portfolio in Q4 2025, for an estimated $37,053,055
- INVESCO LTD. removed 204,126 shares (-21.0%) from their portfolio in Q4 2025, for an estimated $35,601,615
- BOWEN HANES & CO INC added 198,305 shares (+336.3%) to their portfolio in Q4 2025, for an estimated $34,586,375
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 188,450 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $32,867,564
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$BMI Stock Analyst Ratings
Wall Street analysts have issued reports on $BMI in the last several months. We have seen 4 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Underweight" rating on 01/29/2026
- JP Morgan issued a "Overweight" rating on 01/29/2026
- Jefferies issued a "Buy" rating on 01/29/2026
- RBC Capital issued a "Outperform" rating on 10/22/2025
- Stifel issued a "Buy" rating on 10/22/2025
To track analyst ratings and price targets for $BMI Stock, check out Quiver Quantitative's $BMI forecast page.
$BMI Stock Price Targets
Multiple analysts have issued price targets for $BMI recently. We have seen 6 analysts offer price targets for $BMI in the last 6 months, with a median target of $190.5.
Here are some recent targets:
- William Grippin from Barclays set a target price of $136.0 on 01/29/2026
- Michael Fairbanks from JP Morgan set a target price of $190.0 on 01/29/2026
- James Ko from Jefferies set a target price of $200.0 on 01/29/2026
- Jeffrey Reive from RBC Capital set a target price of $191.0 on 01/29/2026
- Nathan Jones from Stifel set a target price of $166.0 on 01/29/2026
- Robert Mason from Baird set a target price of $205.0 on 10/20/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
